Tue. 16 Apr 2024, 3:18am ET
Benzinga
News
ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years
Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART® treatment